| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 23 |
| 1 | ASPIRIN | 19 |
| 2 | ASPIRIN 325 MG | 19 |
| 3 | ASPIRIN 81 MG | 19 |
| 4 | ACETAMINOPHEN | 18 |
| 5 | ACETAMINOPHEN 500MG | 16 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 16 |
| 7 | PAIN RELIEVER | 16 |
| 8 | CLONAZEPAM | 15 |
| 9 | OCTREOTIDE ACETATE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 1 | IPRATROPIUM BROMIDE AND ALBUTEROL | 2 | 0.0007 |
| 2 | SENNOSIDES A AND B | 1 | 0.0006 |
| 3 | CLORAZEPATE DIPOTASSIUM | 1 | 0.0005 |
| 4 | OSILODROSTAT | 1 | 0.0005 |
| 5 | OCTREOTIDE ACETATE | 13 | 0.0004 |
| 6 | DESOXIMETASONE | 7 | 0.0004 |
| 7 | FAMCICLOVIR | 1 | 0.0004 |
| 8 | TERAZOSIN HYDROCHLORIDE | 3 | 0.0003 |
| 9 | SENNOSIDES | 8 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Antirheumatic Agent [EPC] | 10 | 0.0001 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 12 | 0.0001 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Vitamin D Analog [EPC] | 1 | 0.0001 |